Cytomegalovirus-induced T cell responses accelerate Alzheimer’s disease progression in mice

Read full text
Authors: Morgan Marsden, James E. McLaren, Ryan J. Bevan, Daisy Penn-Ripley, Michelle Somerville, Sarah N. Lauder, Manon H Jones, Lila-Blythe Maros, Matthew R McGurk, Awen Gallimore, David A. Price, Kelly L. Miners
+5 more Kristin Ladell, Florian A. Siebzehnrübl, Timothy Hughes, Ian R. Humphreys, Mathew Clement
Cited by: 2
References: 57

Abstract

Infections have long been implicated as causative factors in Alzheimer's disease (AD). Multiple studies have further suggested a key role for herpesviruses, such as cytomegalovirus (CMV). Using transgenic 3xTg-AD mice, we demonstrate that systemic infection with the β-herpesvirus murine CMV (MCMV) accelerates the development of cognitive decline, tauopathy and synaptic loss in the hippocampus, all of which are key features of AD. Accelerated disease progression after infection was associated with substantial lymphocyte infiltration into the brain, dominated by MCMV-specific effector memory CD8+ T cells expressing CXCR3. T cell receptor analyses revealed that clonally diverse virus-specific CD8+ T cells were selectively recruited into the brain during the development of AD. T cell depletion or treatment with the antiviral drug valganciclovir during chronic infection reduced lymphocytic infiltrates in the brain and reversed cognitive decline. These data provide a mechanistic link between chronic viral infections and the development of AD.

Fields of Study & Subjects

Neuroinflammation and Neurodegeneration Mechanisms Tryptophan and brain disorders

Publication details

Journal / source
Brain
Publisher
Oxford University Press (OUP)
Volume
149
Issue
9
Pages
3214–3227
Publication date
31 January 2026
Language
EN